Meeting
2020 ASCO Virtual Scientific Program
Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis.
Authors
Steven Brad Maron
Memorial Sloan Kettering, New York, NY
Steven Brad Maron , Walid Khaled Chatila , Brittanie M Millang , Shalom Sabwa , Joanne F. Chou , Lilan Ling , Rebecca Nagy , Marc Simmons , Richard K. G. Do , Viktoriya Paroder , Hans Gerdes , Pari M. Shah , Geoffrey Yuyat Ku , David H. Ilson , Marinela Capanu , Jaclyn Frances Hechtman , Taha Merghoub , David B. Solit , Nikolaus Schultz , Yelena Yuriy Janjigian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 38: 2020 (suppl; abstr 4559)
DOI
10.1200/JCO.2020.38.15_suppl.4559
Abstract #
4559
Poster Bd #
167
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
First Author: Gemma Bruera
Poster
2014 ASCO Annual Meeting
Molecular evaluation of primary tumor (PT) and synchronous liver metastasis in colorectal cancer (srLmCRC) patients after cetuximab-based chemotherapy.
First Author: Daniela Adua
Poster
2019 Gastrointestinal Cancers Symposium
Genomic alterations in appendiceal carcinoma using circulating DNA.
First Author: Walid Labib Shaib
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock